Gerard Bain, PhD

VP Biomarker Discovery & Development

Gerard Bain joined Boston Pharmaceuticals in 2022 as Vice President, Biomarker Discovery and Development. Previously, Gerard was Senior Director and Head of Translational Sciences at Morphic Therapeutic, where he was responsible for developing and implementing biomarker strategies for clinical and nonclinical programs at the company. Gerard has 25 years of drug discovery and development experience in the pharmaceutical and biotechnology industries and has worked in a variety of therapeutic areas including rare diseases, inflammation, immunology, neurology, tissue repair, fibrosis, and oncology. He is also experienced in drug development using a variety of therapeutic modalities such as small molecules, biologics, mRNA, and gene therapy. Gerard holds a Ph.D. in Biology from McGill University (Montreal, Canada) and a B.S. in Biology from York University (Toronto, Canada).